Loss of Protein Kinase PKR Expression in Human HeLa Cells Complements the Vaccinia Virus E3L Deletion Mutant Phenotype by Restoration of Viral Protein Synthesis

ABSTRACT The E3L proteins encoded by vaccinia virus bind double-stranded RNA and mediate interferon resistance, promote virus growth, and impair virus-mediated apoptosis. Among the cellular proteins implicated as targets of E3L is the protein kinase regulated by RNA (PKR). To test in human cells the role of PKR in conferring the E3L mutant phenotype, HeLa cells stably deficient in PKR generated by an RNA interference-silencing strategy were compared to parental and control knockdown cells following infection with either an E3L deletion mutant (ΔE3L) or wild-type (WT) virus. The growth yields of WT virus were comparable in PKR-sufficient and -deficient cells. By contrast, the single-cycle yield of ΔE3L virus was increased by nearly 2 log10 in PKR-deficient cells over the impaired growth in PKR-sufficient cells. Furthermore, virus-induced apoptosis characteristic of the ΔE3L mutant in PKR-sufficient cells was effectively abolished in PKR-deficient HeLa cells. The viral protein synthesis pattern was altered in ΔE3L-infected PKR-sufficient cells, characterized by an inhibition of late viral protein expression, whereas in PKR-deficient cells, late protein accumulation was restored. Phosphorylation of both PKR and the α subunit of protein synthesis initiation factor 2 (eIF-2α) was elevated severalfold in ΔE3L-infected PKR-sufficient, but not PKR-deficient, cells. WT virus did not significantly increase PKR or eIF-2α phosphorylation in either PKR-sufficient or -deficient cells, both of which supported efficient WT viral protein production. Finally, apoptosis induced by infection of PKR-sufficient HeLa cells with ΔE3L virus was blocked by a caspase antagonist, but mutant virus growth was not rescued, suggesting that translation inhibition rather than apoptosis activation is a principal factor limiting virus growth.

[1]  J. Hiscott Triggering the Innate Antiviral Response through IRF-3 Activation* , 2007, Journal of Biological Chemistry.

[2]  C. Samuel,et al.  Protein Kinase PKR Plays a Stimulus- and Virus-Dependent Role in Apoptotic Death and Virus Multiplication in Human Cells , 2007, Journal of Virology.

[3]  J. Puglisi,et al.  Molecular Framework for the Activation of RNA-dependent Protein Kinase*♦ , 2007, Journal of Biological Chemistry.

[4]  E. Meurs,et al.  The N-terminus of PKR is responsible for the activation of the NF-kappaB signaling pathway by interacting with the IKK complex. , 2006, Cellular signalling.

[5]  M. Katze,et al.  Suppression of Proinflammatory Signal Transduction and Gene Expression by the DualNucleic Acid Binding Domains of the Vaccinia Virus E3L Proteins , 2006, Journal of Virology.

[6]  F. Weber,et al.  Double-Stranded RNA Is Produced by Positive-Strand RNA Viruses and DNA Viruses but Not in Detectable Amounts by Negative-Strand RNA Viruses , 2006, Journal of Virology.

[7]  Y. Suezer,et al.  Double-stranded RNA-binding protein E3 controls translation of viral intermediate RNA, marking an essential step in the life cycle of modified vaccinia virus Ankara. , 2006, The Journal of general virology.

[8]  C. Samuel,et al.  Activation of the RNA-dependent Protein Kinase PKR Promoter in the Absence of Interferon Is Dependent Upon Sp Proteins* , 2006, Journal of Biological Chemistry.

[9]  G. Kochs,et al.  The interferon response circuit: Induction and suppression by pathogenic viruses , 2005, Virology.

[10]  Arvin C. Dar,et al.  Mechanistic Link between PKR Dimerization, Autophosphorylation, and eIF2α Substrate Recognition , 2005, Cell.

[11]  C. Staib,et al.  Role of Viral Factor E3L in Modified Vaccinia Virus Ankara Infection of Human HeLa Cells: Regulation of the Virus Life Cycle and Identification of Differentially Expressed Host Genes , 2005, Journal of Virology.

[12]  G. Kochs,et al.  Inverse interference: how viruses fight the interferon system. , 2004, Viral immunology.

[13]  Michael B. Mathews,et al.  The double-stranded-RNA-binding motif: interference and much more , 2004, Nature Reviews Molecular Cell Biology.

[14]  J. Langland,et al.  Inhibition of PKR by vaccinia virus: role of the N- and C-terminal domains of E3L. , 2004, Virology.

[15]  M. Weiss,et al.  Stress-induced Apoptosis Associated with Null Mutation of ADAR1 RNA Editing Deaminase Gene* , 2004, Journal of Biological Chemistry.

[16]  G. McFadden,et al.  Poxviruses and immune evasion. , 2003, Annual review of immunology.

[17]  A. Rich,et al.  A role for Z-DNA binding in vaccinia virus pathogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Susana Guerra,et al.  Anti-apoptotic and oncogenic properties of the dsRNA-binding protein of vaccinia virus, E3L , 2002, Oncogene.

[19]  J. Langland,et al.  The role of the PKR-inhibitory genes, E3L and K3L, in determining vaccinia virus host range. , 2002, Virology.

[20]  B. Williams,et al.  Blockade of Interferon Induction and Action by the E3L Double-Stranded RNA Binding Proteins of Vaccinia Virus , 2002, Journal of Virology.

[21]  C. Samuel,et al.  Vaccinia virus E3L interferon resistance protein inhibits the interferon-induced adenosine deaminase A-to-I editing activity. , 2001, Virology.

[22]  C. Samuel,et al.  Antiviral Actions of Interferons , 2001, Clinical Microbiology Reviews.

[23]  D. Levy,et al.  IRF3 and IRF7 Phosphorylation in Virus-infected Cells Does Not Require Double-stranded RNA-dependent Protein Kinase R or IκB Kinase but Is Blocked by Vaccinia Virus E3L Protein* , 2001, The Journal of Biological Chemistry.

[24]  B. Jacobs,et al.  Both Carboxy- and Amino-Terminal Domains of the Vaccinia Virus Interferon Resistance Gene, E3L, Are Required for Pathogenesis in a Mouse Model , 2001, Journal of Virology.

[25]  B. Williams,et al.  The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin , 2000, The EMBO journal.

[26]  B. Williams,et al.  PKR; a sentinel kinase for cellular stress , 1999, Oncogene.

[27]  M. Katze,et al.  Inhibition of Double-Stranded RNA-Dependent Protein Kinase PKR by Vaccinia Virus E3: Role of Complex Formation and the E3 N-Terminal Domain , 1998, Molecular and Cellular Biology.

[28]  Tyson V. Sharp,et al.  The vaccinia virus E3L gene product interacts with both the regulatory and the substrate binding regions of PKR: implications for PKR autoregulation. , 1998, Virology.

[29]  E. Paoletti,et al.  Role of the vaccinia virus E3L and K3L gene products in rescue of VSV and EMCV from the effects of IFN-alpha. , 1998, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[30]  C. Samuel,et al.  Adenovirus VAI RNA antagonizes the RNA-editing activity of the ADAR adenosine deaminase. , 1998, Virology.

[31]  T. Cech,et al.  Binding of the protein kinase PKR to RNAs with secondary structure defects: role of the tandem A-G mismatch and noncontiguous helixes. , 1998, Biochemistry.

[32]  C. Rivas,et al.  Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme. , 1998, Virology.

[33]  P. Traktman,et al.  Characterization of the Single-Stranded DNA Binding Protein Encoded by the Vaccinia Virus I3 Gene , 1998, Journal of Virology.

[34]  B. Jacobs,et al.  Complementation of vaccinia virus deleted of the E3L gene by mutants of E3L. , 1997, Virology.

[35]  J. Langland,et al.  Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells , 1997, Journal of virology.

[36]  B. Williams,et al.  Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF‐1 and NF‐κB , 1997, The EMBO journal.

[37]  J. Langland,et al.  When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. , 1996, Virology.

[38]  C. Ho,et al.  Mutational analysis of the vaccinia virus E3 protein defines amino acid residues involved in E3 binding to double-stranded RNA , 1996, Journal of virology.

[39]  H. W. Chang,et al.  Rescue of vaccinia virus lacking the E3L gene by mutants of E3L , 1995, Journal of virology.

[40]  C. Samuel,et al.  Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase , 1995, Molecular and cellular biology.

[41]  E. Evans,et al.  The vaccinia virus D5 protein, which is required for DNA replication, is a nucleic acid-independent nucleoside triphosphatase , 1995, Journal of virology.

[42]  E. Paoletti,et al.  Distinct patterns of IFN sensitivity observed in cells infected with vaccinia K3L- and E3L- mutant viruses. , 1995, Virology.

[43]  M. Perkus,et al.  Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene , 1995, Journal of virology.

[44]  C. Samuel,et al.  Mechanism of interferon action: structure of the mouse PKR gene encoding the interferon-inducible RNA-dependent protein kinase. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[45]  S. B. Lee,et al.  The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. , 1994, Virology.

[46]  O. Elroy-Stein,et al.  Recombinant vaccinia virus K3L gene product prevents activation of double-stranded RNA-dependent, initiation factor 2 alpha-specific protein kinase. , 1993, The Journal of biological chemistry.

[47]  H. W. Chang,et al.  Identification of a conserved motif that is necessary for binding of the vaccinia virus E3L gene products to double-stranded RNA. , 1993, Virology.

[48]  R. Condit,et al.  Temperature-sensitive mutants in the vaccinia virus A18R gene increase double-stranded RNA synthesis as a result of aberrant viral transcription. , 1993, Virology.

[49]  C. Samuel,et al.  The eIF-2 alpha protein kinases, regulators of translation in eukaryotes from yeasts to humans. , 1993, The Journal of biological chemistry.

[50]  B. Moss,et al.  Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope , 1992, Journal of virology.

[51]  H. W. Chang,et al.  The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[52]  C. Samuel,et al.  Mechanism of interferon action: identification of a RNA binding domain within the N-terminal region of the human RNA-dependent P1/eIF-2 alpha protein kinase. , 1992, Virology.

[53]  H. W. Chang,et al.  Characterization of a vaccinia virus-encoded double-stranded RNA-binding protein that may be involved in inhibition of the double-stranded RNA-dependent protein kinase. , 1991, Virology.

[54]  C. Samuel,et al.  Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2α kinase , 1986, Cell.

[55]  C. Samuel,et al.  Mechanism of interferon action. Increased phosphorylation of protein synthesis initiation factor eIF-2 alpha in interferon-treated, reovirus-infected mouse L929 fibroblasts in vitro and in vivo. , 1984, The Journal of biological chemistry.

[56]  C. E. Samuel Mechanism of interferon action: phosphorylation of protein synthesis initiation factor eIF-2 in interferon-treated human cells by a ribosome-associated kinase processing site specificity similar to hemin-regulated rabbit reticulocyte kinase. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[57]  C. Samuel,et al.  Interferon action and the double-stranded RNA-dependent enzymes ADAR1 adenosine deaminase and PKR protein kinase. , 2006, Progress in nucleic acid research and molecular biology.

[58]  C. Samuel,et al.  Mechanism of Interferon Action: Biochemical and Genetic Evidence for the Intermolecular Association of the RNA-Dependent Protein Kinase PKR from Human Cells , 1996 .